logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
22/09/2025
Bayer has announced that it has begun a Phase III clinical trial for an experimental stem cell therapy for Parkinson's disease.
Latest
2 m ago
E Fund Management has reduced its holdings of Tiger Medicine (03347.HK) by 876,900 shares, with each share priced at approximately 46.57 Hong Kong dollars.
3 m ago
Group Chief Financial Officer Zhang Yuxia sold 50,000 shares of Minsheng Group (00425.HK) at a price of 36.06 Hong Kong dollars per share.
3 m ago
Citi reduces its holdings in China Taiping Insurance (02601.HK) by approximately 13.6443 million shares, with a price per share of approximately 31.96 Hong Kong dollars.
3 m ago
Barclays PLC increases its holdings in Longpan Technology (02465) by 12.49 million shares, with a price of approximately HK$12.26 per share.
3 m ago
Ocean Electric: Submitting Applications for Overseas Listing and Share Issuance Listing
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.